Wright Medical Group NV

( )
WMGI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.55%461.501.0%$725.86m
ABTAbbott Laboratories 0.01%118.300.8%$614.96m
MDTMedtronic Plc 0.10%125.270.6%$529.14m
DHRDanaher Corp. 0.11%253.940.7%$510.73m
ISRGIntuitive Surgical, Inc. 0.00%833.382.3%$509.12m
BDXBecton, Dickinson & Co. -0.04%242.381.0%$368.36m
BSXBoston Scientific Corp. -0.08%41.511.0%$364.23m
ALGNAlign Technology, Inc. 0.00%569.046.3%$329.80m
DXCMDexCom, Inc. -0.08%333.007.8%$287.81m
SYKStryker Corp. -0.13%252.951.3%$273.97m
EWEdwards Lifesciences Corp. -0.06%89.490.4%$251.53m
BAXBaxter International, Inc. 0.05%83.861.8%$206.48m
AAgilent Technologies, Inc. 0.11%131.301.6%$196.63m
IDXXIDEXX Laboratories, Inc. -0.01%530.003.8%$189.54m
ZBHZimmer Biomet Holdings, Inc. 0.08%167.271.7%$174.52m

Company Profile

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.